Novel Excipient Regulatory Pathway

Novel excipient regulatory pathway addresses substances lacking established safety profiles requiring additional testing. Toxicology studies establish acceptable safety limits. Clinical tolerance assessment evaluates human safety. Regulatory submissions provide comprehensive characterisation. Approval timelines extend from limited regulatory precedent.

Excipient innovation enables improved formulation performance. Safety profiles sometimes provide novel therapeutic benefits. Patent protection encourages excipient innovation. Regulatory guidance evolves addressing novel substances. International harmonisation reduces redundant testing.